Skinvisible Statistics
Total Valuation
Skinvisible has a market cap or net worth of $276,930. The enterprise value is $6.43 million.
Market Cap | 276,930 |
Enterprise Value | 6.43M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
Skinvisible has 4.54 million shares outstanding.
Shares Outstanding | 4.54M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 3.40% |
Owned by Institutions (%) | n/a |
Float | 4.35M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 13.85 |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 321.46 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.01
Current Ratio | 0.01 |
Quick Ratio | 0.01 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -2.92 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -3,164.33% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | $10,000 |
Profits Per Employee | -$2.58M |
Employee Count | 2 |
Asset Turnover | 0.11 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, Skinvisible has paid $3.11 million in taxes.
Income Tax | 3.11M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.02% in the last 52 weeks. The beta is -0.39, so Skinvisible's price volatility has been lower than the market average.
Beta (1Y) | -0.39 |
52-Week Price Change | +2.02% |
50-Day Moving Average | 0.08 |
200-Day Moving Average | 0.08 |
Relative Strength Index (RSI) | 38.42 |
Average Volume (30 Days) | 1,064 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Skinvisible had revenue of $20,000 and -$5.15 million in losses. Loss per share was -$1.13.
Revenue | 20,000 |
Gross Profit | 1,229 |
Operating Income | -490,377 |
Pretax Income | -2.38M |
Net Income | -5.15M |
EBITDA | -471,603 |
EBIT | -490,374 |
Loss Per Share | -$1.13 |
Balance Sheet
The company has $888 in cash and $6.15 million in debt, giving a net cash position of -$6.15 million or -$1.36 per share.
Cash & Cash Equivalents | 888 |
Total Debt | 6.15M |
Net Cash | -6.15M |
Net Cash Per Share | -$1.36 |
Equity / Book Value | -9.02M |
Book Value Per Share | -1.99 |
Working Capital | -3.48M |
Cash Flow
In the last 12 months, operating cash flow was -$77,157 and capital expenditures -$9,333, giving a free cash flow of -$86,490.
Operating Cash Flow | -77,157 |
Capital Expenditures | -9,333 |
Free Cash Flow | -86,490 |
FCF Per Share | -$0.02 |
Margins
Gross margin is 6.15%, with operating and profit margins of -2,451.89% and -25,768.53%.
Gross Margin | 6.15% |
Operating Margin | -2,451.89% |
Pretax Margin | -11,912.20% |
Profit Margin | -25,768.53% |
EBITDA Margin | -2,358.02% |
EBIT Margin | -2,451.87% |
FCF Margin | -432.45% |
Dividends & Yields
Skinvisible does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -1,861.01% |
FCF Yield | -31.23% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 4, 2019. It was a reverse split with a ratio of 1:50.
Last Split Date | Jan 4, 2019 |
Split Type | Reverse |
Split Ratio | 1:50 |
Scores
Skinvisible has an Altman Z-Score of -373.92 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -373.92 |
Piotroski F-Score | 1 |